Julen Cortazar-Tomas

Bizkaia Science And Technology Park
Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge.

Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge.

Journal: ACS infectious diseases
Published: March 25, 2025

The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines.

The novel antigen, lipopolysaccharide export protein LptH, protects mice against Pseudomonas aeruginosa acute pneumonia in monovalent and multivalent vaccines.

Journal: Vaccine
Published: March 07, 2025

Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.

Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.

Journal: Frontiers in immunology
Published: June 07, 2024

Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ.

Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ.

Journal: NPJ vaccines
Published: April 24, 2024

BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system.

BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system.

Journal: Vaccine: X
Published: July 11, 2023

Correction: Quinn et al. GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 2023, 11, 175.

Correction: Quinn et al. GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 2023, 11, 175.

Journal: Vaccines
Published: June 14, 2023

Dome1-JAK-STAT signaling between parasite and host integrates vector immunity and development.

Dome1-JAK-STAT signaling between parasite and host integrates vector immunity and development.

Journal: Science (New York, N.Y.)
Published: January 12, 2023

The Ixodes ricinus salivary gland proteome during feeding and B. Afzelii infection: New avenues for an anti-tick vaccine.

The Ixodes ricinus salivary gland proteome during feeding and B. Afzelii infection: New avenues for an anti-tick vaccine.

Journal: Vaccine
Published: November 26, 2022

GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection.

GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection.

Journal: Vaccines
Published: November 19, 2022

Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.

Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.

Journal: Vaccine
Published: July 10, 2022

Structural Analysis of the Black-Legged Tick Saliva Protein Salp15.

Structural Analysis of the Black-Legged Tick Saliva Protein Salp15.

Journal: International journal of molecular sciences
Published: February 15, 2022

BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.

BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.

Journal: Frontiers in immunology
Published: August 30, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026